Upregulation of HLA Class I Expression on Tumor Cells by the Anti-EGFR Antibody Nimotuzumab-Reference-Cited by-同舟云学术

Upregulation of HLA Class I Expression on Tumor Cells by the Anti-EGFR Antibody Nimotuzumab

Published:2017-10-06 Issue: Volume:8 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Garrido Greta,Rabasa Ailem,Garrido Cristina,Chao Lisset,Garrido Federico,García-Lora Ángel M.,Sánchez-Ramírez Belinda

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference47 articles.

1. Molecular mechanism for a role of SHP2 in epidermal growth factor receptor signaling.;Agazie;Mol. Cell. Biol.,2003

2. Inhibition of mammary tumor cell adhesion, migration, and invasion by the selective synthetic urokinase inhibitor B428.;Alonso;Anticancer. Res.,1998

3. Establishment and characterization of cell lines from human small cell and large cell carcinomas of the lung.;Bergh;Acta Pathol. Microbiol. Immunol. Scand. A Pathol.,1985

4. Nimotuzumab treatment of malignant gliomas.;Bode;Exp. Opin. Biol. Ther.,2012

5. Selective BRAFV600E inhibition enhances T-cell recognition of melanoma without affecting lymphocyte function.;Boni;Cancer Res.,2010

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing immunotherapy through PD‐L1 upregulation: the promising combination of anti‐PD‐L1 plus mTOR inhibitors;Molecular Oncology;2024-09-11

2. Unveiling the regulatory mechanism of nimotuzumab on PD-L1 expression in head and neck squamous cell carcinoma patients: Implications for enhanced anticancer treatment strategies;Cellular Signalling;2024-09

3. The story of EGFR: from signaling pathways to a potent anticancer target;Future Medicinal Chemistry;2022-09

4. EGFR amplification is a putative resistance mechanism for NSCLC–LM patients with TKI therapy and is associated with poor outcome;Frontiers in Oncology;2022-08-01

5. EGFR-Mutated Non-Small Cell Lung Cancer and Resistance to Immunotherapy: Role of the Tumor Microenvironment;International Journal of Molecular Sciences;2022-06-10